STAT4- and STAT6-signaling molecules in a murine model of multiple sclerosis

Moses Rodriguez1, Laurie Zoecklein, Jeffrey D Gamez

  • 1Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA. rodriguez.moses@mayo.edu

Insights

A novel mouse model reveals that STAT4 deficiency leads to a delayed onset of demyelination after Theiler

Area of Science:

  • Immunology
  • Neuroscience
  • Virology

Background:

  • Epidemiological studies suggest early-life environmental factors, potentially viral, may trigger multiple sclerosis (MS) later in life.
  • Current MS models show rapid inflammation/demyelination post-infection, unlike the proposed delayed onset in humans.
  • The role of STAT4 in immune responses and its potential link to delayed demyelination remains unclear.

Purpose of the Study:

  • To investigate the role of STAT4 in T cell responses following Theiler's virus infection.
  • To establish and characterize a novel mouse model for studying late-onset demyelination relevant to MS.

Main Methods:

  • Infection of STAT4-deficient (STAT4-/-) and STAT6-deficient mice with Theiler's virus.
  • Monitoring for demyelination, inflammation, viral RNA levels, and antigen expression over an extended period (180+ days).
  • Bone marrow reconstitution experiments to determine the immune system's role in demyelination.

Main Results:

  • STAT4-/- mice showed resistance to demyelination for 180 days post-infection, followed by severe demyelination.
  • Lesions in STAT4-/- mice exhibited inflammatory cells and upregulated MHC Class I and II antigens.
  • Demyelination correlated with virus antigen expression, despite high viral RNA levels throughout infection.

Conclusions:

  • Theiler's virus infection in STAT4-/- mice provides a new model for late-onset demyelination.
  • The STAT4-/- immune system is critical for the observed delayed demyelination.
  • This model may help elucidate immune mechanisms underlying late-onset demyelination in multiple sclerosis.